Company Filing History:
Years Active: 2018-2022
Title: Mi Zeng - Innovator in Pharmaceutical Compounds
Introduction
Mi Zeng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents to his name, Zeng continues to push the boundaries of scientific research and application.
Latest Patents
Zeng's latest patents include groundbreaking work on cyclohexyl benzamide compounds. This patent describes a compound of the Formula (1), where R1-R5 are defined in the description, and each '*' represents a chiral center. Another significant patent focuses on GPR142 agonist compounds, providing compounds of the Formula (Ia) wherein R is selected from various groups, including CH, CH(CH), and CHC(O)OCH(CH). These innovations highlight Zeng's expertise in creating complex chemical structures with potential therapeutic applications.
Career Highlights
Mi Zeng is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to pharmaceutical research.
Collaborations
Zeng has worked alongside talented colleagues, including Zhi Long Hu and Lian Zhu Liu. Their collaborative efforts have fostered an environment of innovation and creativity, leading to the development of new and effective pharmaceutical solutions.
Conclusion
Mi Zeng's contributions to the field of pharmaceuticals through his innovative patents and collaborations exemplify the spirit of scientific advancement. His work continues to impact the industry positively, paving the way for future discoveries.